Gisela Carolina De La Torre Gómez

Head of the Proteomic Unit

Josep Carreras Leukaemia Research Institute

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gisela Carolina De La Torre Gómez is the Head of the Proteomic Unit at the Josep Carreras Leukaemia Research Institute in Spain. Her research focuses on bioactive peptides, proteomics related to SARS-CoV-2 infection, and the role of various proteins in cell cycle regulation and plant immunity. She also investigates the molecular mechanisms underlying tumor behavior and therapeutic responses in cancer.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Juan Luis Vives Corrons

Josep Carreras Leukaemia Research Institute

SPAIN

View details

Carlos Casasnovas Pons

Professor Associat

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gisela Carolina De La Torre Gómez

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Discovery, Characterization, and Quantification of Bioactive Peptides Contained in Palbio Porcine Intestinal Mucosa Hydrolysate Products

SARS-CoV-2 Infection and Anemia—A Focus on RBC Deformability and Membrane Proteomics—Integrated Observational Prospective Study

N<SUP>α</SUP>-acetyltransferase NAA50 mediates plant immunity independent of the N<SUP>α</SUP>-acetyltransferase A complex

Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity

Narazaciclib, a Differentiated CDK4/6 Antagonist, Prolongs Cell Cycle Arrest and Metabolomic Reprogramming, Enabling Restoration of Ibrutinib Sensitivity in Btki-Resistant Mantle Cell Lymphoma

Narazaciclib, a Differentiated CDK4/6 Antagonist, Prolongs Cell Cycle Arrest and Metabolomic Reprogramming, Enabling Restoration of Ibrutinib Sensitivity in BtkiResistant Mantle Cell Lymphoma

TOR complex 1 negatively regulates NDR kinase Cbk1 to control cell separation in budding yeast

TOR complex 1 negatively regulates NDR kinase Cbk1 to control cell separation in budding yeast

Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas

Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase <i>NSUN7</i> is associated with clinical outcome and therapeutic vulnerability in liver cancer

Collaborators (2)

Juan Luis Vives Corrons

Carlos Casasnovas Pons

Make your next move.